Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q969P5: Variant p.Gly243Arg

F-box only protein 32
Gene: FBXO32
Feedback?
Variant information Variant position: help 243 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glycine (G) to Arginine (R) at position 243 (G243R, p.Gly243Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help Found in patients with familial dilated cardiomyopathy; likely pathogenic; impairs the formation of SCF complex; reduced ubiquitination of cellular proteins. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 243 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 355 The length of the canonical sequence.
Location on the sequence: help LTFTDLPLCLQLNIMQRLSD G RDLVSLGQAAPDLHVLSEDR The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         LTFTDLPLCLQLNIMQRLSDGRDLVSLGQAAPDLHVLSEDR

Mouse                         LTITDLPVCLQLNIMQRLSDGRDLVSLGQAAPDLHVLSEDR

Rat                           LTITDLPVCLQLNIMQRLSDGRDLVSLGQAAPDLHVLSEDR

Pig                           LTFTDLPLCLQLNIMQRLSDGRDLVSLGQVAPDLHVLSEDR

Bovine                        LTFTDLPLCLQLNIMQRLSDGRDLVSLGQVAPDLHVLSEDR
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 355 F-box only protein 32
Domain 223 – 271 F-box



Literature citations
A substitution mutation in cardiac ubiquitin ligase, FBXO32, is associated with an autosomal recessive form of dilated cardiomyopathy.
Al-Hassnan Z.N.; Shinwari Z.M.; Wakil S.M.; Tulbah S.; Mohammed S.; Rahbeeni Z.; Alghamdi M.; Rababh M.; Colak D.; Kaya N.; Al-Fayyadh M.; Alburaiki J.;
BMC Med. Genet. 17:3-3(2016)
Cited for: INVOLVEMENT IN DCM; VARIANT ARG-243; SUBCELLULAR LOCATION; FBXO32, encoding a member of the SCF complex, is mutated in dilated cardiomyopathy.
Al-Yacoub N.; Shaheen R.; Awad S.M.; Kunhi M.; Dzimiri N.; Nguyen H.C.; Xiong Y.; Al-Buraiki J.; Al-Habeeb W.; Alkuraya F.S.; Poizat C.;
Genome Biol. 17:R2.1-R2.11(2016)
Cited for: INVOLVEMENT IN DCM; VARIANT ARG-243; CHARACTERIZATION OF VARIANT ARG-243; SUBUNIT;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.